The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2024 | The importance of protecting cardiovascular health in cancer patients
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA, emphasizes the importance of maintaining cardiovascular health in cancer patients. Given that cardiovascular comorbidities are common in older patients, it’s crucial that cancer treatments do not harm cardiovascular health and that managing cancer does not come at the cost of reduced cardiovascular well-being. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
